Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study

BACKGROUND: We previously established a 53-gene prognostic signature for overall survival (OS) of gastric cancer patients. This retrospective multi-center study aimed to develop a clinically applicable gene expression detection assay and to investigate the prognostic value of this signature. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Linghua, Wang, Haifeng, Jiang, Chengfei, Li, Wenhuan, Zhai, Shuting, Cai, Xiujun, Wang, Xianfa, Liao, Linghong, Tao, Feng, Jin, Dexi, Chen, Guofu, Xia, Yankai, Mao, Jian-Hua, Li, Bin, Wang, Pin, Hang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569189/
https://www.ncbi.nlm.nih.gov/pubmed/33069062
http://dx.doi.org/10.1016/j.ebiom.2020.103023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569189/
https://www.ncbi.nlm.nih.gov/pubmed/33069062
http://dx.doi.org/10.1016/j.ebiom.2020.103023

Ejemplares similares